Cardiotoxicity in a dish: new insights for personalized therapy

被引：4

作者：

Biermann, Mitch ^{[1
,2
,3
]}

Kamp, Timothy J. ^{[1
,2
,3
]}

机构：

[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Biol, Madison, WI USA

[2] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI USA

[3] Univ Wisconsin, Stem Cell & Regenerat Med Ctr, Madison, WI USA

来源：

NATURE MEDICINE | 2016年 / 22卷 / 05期

关键词：

D O I：

10.1038/nm.4095

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A recent study identifies differences in human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes from patients with breast cancer who were treated with doxorubicin and either did or did not develop cardiotoxicity. The results open up new avenues for the development of personalized therapy and the prevention of cardiotoxicity.

引用

页码：459 / 460

页数：2

共 4 条

[1] Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity [J].

Burridge, Paul W. ;

Li, Yong Fuga ;

Matsa, Elena ;

Wu, Haodi ;

Ong, Sang-Ging ;

Sharma, Arun ;

Holmstrom, Alexandra ;

Chang, Alex C. ;

Coronado, Michael J. ;

Ebert, Antje D. ;

Knowles, Joshua W. ;

Telli, Melinda L. ;

Witteles, Ronald M. ;

Blau, Helen M. ;

Bernstein, Daniel ;

Altman, Russ B. ;

Wu, Joseph C. .

NATURE MEDICINE, 2016, 22 (05) :547-556

[2]

Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]

[3] Cardiotoxicity of anticancer treatments [J].

Ewer, Michael S. ;

Ewer, Steven M. .

NATURE REVIEWS CARDIOLOGY, 2015, 12 (09) :547-558

[4] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].

Slamon, DJ ;

Leyland-Jones, B ;

Shak, S ;

Fuchs, H ;

Paton, V ;

Bajamonde, A ;

Fleming, T ;

Eiermann, W ;

Wolter, J ;

Pegram, M ;

Baselga, J ;

Norton, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792

← 1 →